07:00 , Oct 14, 2002 |  BioCentury  |  Strategy

Spendthrifty

One of the more important benefits of the 1999-2000 funding frenzy was that companies were given enough money to generate broad pipelines. Coming into 2001 flush with cash, CEOs were able to turn up the...
08:00 , Mar 25, 2002 |  BC Week In Review  |  Company News

ApoImmune, Large Scale Biology deal

LSBC will produce two of ApoImmune’s polypeptides for use as cancer vaccine adjuvants. The deal combines LSBC’s GeneWare manufacturing technology with ProtEx cancer cell targeting technology from ApoImmune. ApoImmune Inc. , Louisville, Ky.   Large...
08:00 , Mar 22, 2002 |  BC Extra  |  Company News

LSBC, ApoImmune protein production deal

Large Scale Biology (LSBC) will produce two of ApoImmune's polypeptides for use as cancer vaccine adjuvants. The deal combines LSBC's GeneWare manufacturing technology with ProtEx cancer cell targeting technology from ApoImmune (Louisville, Ky.)....